Copyright: ©Author(s) 2026.
World J Crit Care Med. Sep 9, 2026; 15(3): 122062
Published online Sep 9, 2026. doi: 10.5492/wjccm.122062
Published online Sep 9, 2026. doi: 10.5492/wjccm.122062
Figure 2 Top circulating markers in studies with measures of venous congestion.
Circulating markers reported by > 3% of studies (5 or more studies) are shown. Cardiovascular and endothelial signaling proteins were the most frequently reported proteins. The bar graph demonstrates the number of studies (Y-axis) that reported clinical associations or findings with the identified proteins (X-axis). The proportion (%) of the 145 studies that report each protein is included above the green bars. The pie charts represent the disease states in which the proteins were quantified (cardiac: Dark blue; pulmonary: Light blue; renal: Beige; hepatic/abdominal: White; peripheral congestion: Grey). A complete list of all reported circulating markers with associations with results or outcomes in studies with measures of venous congestion is shown in Supplementary Table 2. BNP: B-type natriuretic peptide; ET-1: Endothelin 1; VEGF: Vascular endothelial growth factor; CRP: C-reactive protein; IL-6: Interleukin-6; TNF: Tumor necrosis factor; FGF: Fibroblast growth factor.
- Citation: Van Nynatten LR, Nabieva K, Barber G, Moroniti JJ, Iansavitchene A, Prager R, Slessarev M, Basmaji J, Leligdowicz A. Characterizing the molecular landscape of venous congestion. World J Crit Care Med 2026; 15(3): 122062
- URL: https://www.wjgnet.com/2220-3141/full/v15/i3/122062.htm
- DOI: https://dx.doi.org/10.5492/wjccm.122062